Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers
Authors:
Open Access
- 21 May 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Protein & Cell
- Vol. 10 (11) , 808-824
Abstract
While the majority of all human cancers counteract telomere shortening by expressing telomerase, ~15% of all cancers maintain telomere length by a telomerase-independent mechanism known as alternative lengthening of telomeres (ALT). Here, we show that high load of intrinsic DNA damage is present in ALT cancer cells, leading to apoptosis stress by activating p53-independent, but JNK/c-Myc-dependent apoptotic pathway. Notably, ALT cells expressing wild-type p53 show much lower apoptosis than p53-deficient ALT cells. Mechanistically, we find that intrinsic DNA damage in ALT cells induces low level of p53 that is insufficient to initiate the transcription of apoptosis-related genes, but is sufficient to stimulate the expression of key components of mTORC2 (mTOR and Rictor), which in turn leads to phosphorylation of AKT. Activated AKT (p-AKT) thereby stimulates downstream anti-apoptotic events. Therefore, p53 and AKT are the key factors that suppress spontaneous apoptosis in ALT cells. Indeed, inhibition of p53 or AKT selectively induces rapid death of ALT cells in vitro, and p53 inhibitor severely suppresses the growth of ALT-cell xenograft tumors in mice. These findings reveal a previously unrecognized function of p53 in anti-apoptosis and identify that the inhibition of p53 or AKT has a potential as therapeutics for specifically targeting ALT cancers.Keywords
This publication has 54 references indexed in Scilit:
- Alternative lengthening of telomeres in normal mammalian somatic cellsGenes & Development, 2013
- Low-level p53 expression changes transactivation rules and reveals superactivating sequencesProceedings of the National Academy of Sciences, 2012
- Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres PathwayPLOS Genetics, 2012
- Antitelomerase Therapy Provokes ALT and Mitochondrial Adaptive Mechanisms in CancerCell, 2012
- TBK1 Directly Engages Akt/PKB Survival Signaling to Support Oncogenic TransformationMolecular Cell, 2011
- Aurora B Interacts with NIR-p53, Leading to p53 Phosphorylation in Its DNA-binding Domain and Subsequent Functional SuppressionJournal of Biological Chemistry, 2011
- p53 Research: The Past Thirty Years and the Next Thirty YearsCold Spring Harbor Perspectives in Biology, 2010
- Impact of mutant p53 functional properties onTP53mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 databaseHuman Mutation, 2007
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994